SREBF1 and hepatocellular carcinoma: One study found that the interaction between the HCC-associated protein TD26 and the truncated nuclear SREBP1 form (nSREBP1) could block AMPK-mediated SREBP1 inhibition, resulting in increased lipogenesis and enhanced HCC progression (Wang et al., 2018).